Donald Notman insider trades
Open-market stock purchases and sales by Donald Notman, Chief Operating Officer at Ocular Therapeutix, Inc, from SEC Form 4 filings since Oct 2, 2017.
Track record: 100% of 3 scored buys are up 5% or more since purchase, averaging +41%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Aug 31, 2026 | OCUL Ocular Therapeutix, Inc | Sold | $11.3K |
| Feb 12, 2026 | OCUL Ocular Therapeutix, Inc | Sold | $103K |
| Feb 4, 2026 | OCUL Ocular Therapeutix, Inc | Sold | $51.5K |
| Feb 2, 2026 | OCUL Ocular Therapeutix, Inc | Sold | $49.9K |
| Jan 2, 2026 | OCUL Ocular Therapeutix, Inc | Bought (not open market) | — |
| Jan 2, 2026 | OCUL Ocular Therapeutix, Inc | Bought (not open market) | — |
Companies traded
- OCUL Ocular Therapeutix, Inc: 3 buys, 10 sales, last Aug 31, 2026